Tatva Chintan Pharma Chem schedules investor meetings on September 23
- Tatva Chintan Pharma Chem plans virtual investor meetings on September 23, 2026
- Interactions include Ask Investment Managers Limited and other analysts
- Disclosures made under SEBI LODR Regulation 30 to BSE and NSE
- Discussions limited to publicly available information only
*this image is generated using AI for illustrative purposes only.
Tatva Chintan Pharma Chem Limited will hold one-to-one meetings with various analysts and investors on September 23, 2026. The interactions are scheduled to take place via a virtual platform.
The company disclosed the schedule pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted to the Bombay Stock Exchange and the National Stock Exchange of India Limited.
Meeting Details
| Date | Participant | Type | Mode |
|---|---|---|---|
| September 23, 2026 | Ask Investment Managers Limited | One-to-One Meeting | Virtual Meeting |
The company stated that discussions during the interaction will be based solely on publicly available information. No unpublished price-sensitive information (UPSI) will be shared. The intimation is subject to change if necessary and has been made available on the company’s website.
Historical Stock Returns for Tatva Chintan Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.52% | +0.77% | +12.83% | +53.58% | +69.00% | 0.0% |
How might the insights shared with Ask Investment Managers influence broader market sentiment toward Tatva Chintan Pharma's stock in the short term?
Does this scheduled interaction signal any upcoming strategic shifts or operational updates for the company beyond publicly available data?
What specific growth metrics or pipeline developments are analysts likely to scrutinize during these virtual meetings?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
